Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,774Revenue $M2,921Net Margin (%)14.3Altman Z-Score1.5
Enterprise Value $M12,573EPS $1.2Operating Margin %12.5Piotroski F-Score5
P/E(ttm)21.8Beneish M-Score-2.1Pre-tax Margin (%)7.4Higher ROA y-yY
Price/Book5.610-y EBITDA Growth Rate %--Quick Ratio1.0Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %--Current Ratio1.1Lower Leverage y-yN
Price/Free Cash Flow29.4y-y EBITDA Growth Rate %74.3ROA % (ttm)5.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)25.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M329ROIC % (ttm)12.8Gross Margin Increase y-yN

Gurus Latest Trades with IMS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IMSVanguard Health Care Fund 2014-12-31 Add0.15%$23.88 - $26.33
($25.23)
$ 26.646%Add 25.80%11,995,380
IMSFirst Eagle Investment 2014-12-31 Sold Out -0.039%$23.88 - $26.33
($25.23)
$ 26.646%Sold Out0
IMSVanguard Health Care Fund 2014-06-30 Buy 0.65%$22.83 - $25.45
($24.01)
$ 26.6411%New holding9,535,580
IMSFirst Eagle Investment 2014-06-30 Buy 0.04%$22.83 - $25.45
($24.01)
$ 26.6411%New holding606,452
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IMS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


IMS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Knightly Kevin CSVP, Information Offerings 2015-11-23Sell19,231$28.5-7.86view
Knightly Kevin CSVP, Information Offerings 2015-11-19Sell55,000$28.37-7.44view
TPG Group Holdings (SBS) Advis10% Owner 2015-08-11Sell12,563,176$31.17-15.75view
CPP Investment Board Private H10% Owner 2015-08-11Sell10,541,518$31.17-15.75view
DANHAKL JOHN GDirector 2015-08-05Sell2,166,065$31.17-15.75view
Green Equity Investors V, L.P.Director 2015-08-05Sell2,166,065$31.17-15.75view
CPP Investment Board Private H10% Owner 2015-05-12Sell30,554,584$26.68-1.57view
Green Equity Investors V, L.P.Director 2015-05-12Sell6,278,340$26.78-1.94view
DANHAKL JOHN GDirector 2015-05-12Sell6,278,340$26.78-1.94view
TPG Group Holdings (SBS) Advis10% Owner 2015-05-12Sell36,414,368$26.78-1.94view

Quarterly/Annual Reports about IMS:

    News about IMS:

    Articles On GuruFocus.com
    Larry Robbins Exits McDonald's, Paypal, Fossil Jan 14 2016 
    Healthcare Informatics: A Value Investor’s Perspective Oct 23 2015 
    Weekly Insider Sells Highlight: IMS, NOW, BMY, EA Aug 11 2015 
    Weekly Insider Sells Highlight: FSL, IMS, EA, PANW May 17 2015 
    Weekly Insider Sells Highlight: BPZ, IMS, TDG, GIS, UNP Apr 14 2014 

    More From Other Websites
    IMS Health to Announce First-Quarter 2016 Results on May 4, 2016 Apr 20 2016
    IMS Health to Announce First-Quarter 2016 Results on May 4, 2016 Apr 20 2016
    IMS Health Named a Leading Outsourcing Provider by International Association of Outsourcing... Apr 18 2016
    High-priced drugs helped push prescription spending up 8.5% in 2015 Apr 14 2016
    IMS Health Study: U.S. Drug Spending Growth Reaches 8.5 Percent in 2015 Apr 14 2016
    Report: US medicine spending up 8.5 percent 2015 Apr 14 2016
    Report: US medicine spending up 8.5 percent 2015 Apr 14 2016
    U.S. Drug Spending Climbs Apr 13 2016
    U.S. prescription drug spending to hit $400 bln a year by 2020 -IMS Apr 13 2016
    U.S. prescription drug spending to hit $400 bln a year by 2020 -IMS Apr 13 2016
    IMS HEALTH HOLDINGS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Apr 08 2016
    IMS Health: Surge in Biosimilars to Drive Significant Change in Health System Costs, Patient Access... Mar 29 2016
    Release of the Super-Junction MOSFET “Super J MOS® S2/S2FD Series” Mar 28 2016
    Hikma subsidiary receives FDA approval for Temozolomide capsules Mar 28 2016
    IMS Health and Hootsuite Form Alliance to Help Life Sciences Companies Increase Engagement on Social... Mar 16 2016
    Servier Russia Deploys IMS Health’s Nexxus Mobile Intelligence CRM Solution To Drive Commercial... Mar 14 2016
    IMS Health to Deliver Keynote Address on Orchestrated Customer Engagement at eyeforpharma Barcelona... Mar 14 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)